ArticleFrontiers in public health2025
Global, regional, and national burden of chlamydial infection: a systematic analysis of incidence, prevalence, deaths, and DALYs with projections to 2046.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- An Exploratory In Silico Analysis ofCancers · 2026Article
- Global temporal trends and projections for the incidence of chlamydial infection among women of childbearing age over the next decade.Medicine · 2026Article
- CtGAP 2.0: enhanced genome assembly, strain resolution, and phylogenomics forMicrobiology resource announcements · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chlamydial infection, a major sexually transmitted disease caused by Methods: Data from the Global Burden of Disease (GBD) 2021 study were analyzed. We estimated 2021 burden metrics, evaluated temporal trends from 1990 to 2021 using estimated annual percentage changes (EAPC), and projected trends for 2022-2046 using an age-period-cohort (APC) model. Results: In 2021, global incidence was 235.7 million [95% uncertainty intervals (UI): 172.9-334.7 million] with an age-standardized incidence rate (ASIR) of 2902.13/100,000; prevalence was 152.2 million [113.2-213.0 million; age-standardized prevalence rate (ASPR): 1874.56/100,000]. There were 1,033 deaths [683-1,370; age-standardized deaths rate (ASDR): 0.01/100,000] and 163,617 disability-adjusted life-years (DALYs) [116,493-227,160; age-standardized DALYs rate (ASDAR): 2.01/100,000]. Geographic disparities were striking: Southern Sub-Saharan Africa and Central Asia had the highest ASIR, while Western Europe and High-income North America had the lowest. Asia bore the largest absolute burden. Males showed higher incidence rates, while females experienced higher prevalence, deaths, and DALYs. Temporal trends (1990-2021) showed fluctuating case counts and declining age-standardized rates (ASRs), with regional variations. Projections to 2046 indicate divergent sex-specific trends, with rising female ASIR/ASPR but declining absolute cases among males. Conclusion: Chlamydial infection exhibits marked global disparities, necessitating targeted interventions including region-specific strategies and gender-responsive care to reduce its burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.